Company PharmaResources (Shanghai) Co., Ltd.

Equities

301230

CNE1000065Q9

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for PharmaResources (Shanghai) Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
32.49 ^CNY	-5.55%		-11.54%	-9.25%

25/04	PharmaResources Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23/04	PharmaResources Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PharmaResources Shanghai Co Ltd is a China-based company mainly engaged in the development and commercial production of new drugs. The Company's main businesses include drug discovery, process research and development and commercial manufacturing business. The drug discovery business includes medicinal chemistry, synthetic chemistry and pharmacokinetics. The process research and development business includes process chemistry and process development as well as bulk drug research. The commercial manufacturing business includes customized manufacturing of new drugs and the research and development, production and sales of proprietary generic drug products. The Company distributes its products to the United States, India and other countries.

Number of employees: 1,047

CNY in Million	2022	Weight	2023	Weight	Delta
Drug Discovery 59.9 %	275	57.4 %	293	59.9 %	+6.73%
Commercial Production 22.3 %	117	24.5 %	109	22.3 %	-6.57%
Process Research and Development 15.9 %	80	16.8 %	78	15.9 %	-3.04%
Other 1.9 %	7	1.4 %	9	1.9 %	+36.64%

CNY in Million	2022	Weight	2023	Weight	Delta
Foreign 69.8 %	339	70.7 %	342	69.8 %	+1.00%
China 30.2 %	140	29.3 %	148	30.2 %	+5.30%

Managers	Title	Age	Since
Ping Chen CEO	Chief Executive Officer	66	14/07/14
Shi Cheng Li DFI	Director of Finance/CFO	47	01/14/01
Xiao Jing He BRD	Director/Board Member	38	01/09/01
Sheng Li Jiang BRD	Director/Board Member	53	01/07/01

Members of the board	Title	Age	Since
Qi Dong You BRD	Director/Board Member	69	01/20/01
Zheng Fei BRD	Director/Board Member	51	01/13/01
Chun Yang Shao BRD	Director/Board Member	60	01/20/01
Ping Chen CEO	Chief Executive Officer	66	14/07/14
Sheng Li Jiang BRD	Director/Board Member	53	01/07/01
Rong Chang An BRD	Director/Board Member	59	01/14/01
Li Cheng BRD	Director/Board Member	53	01/20/01
Guo Dong Liu CHM	Chairman	46	01/17/01
Xue Jun Dong BRD	Director/Board Member	60	01/15/01
Xiao Jing He BRD	Director/Board Member	38	01/09/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	107,622,666	34,255,536 ( 31.83 %)	0	31.83 %

Name	Equities	%	Valuation
Zhong Ou Asset Management Co., Ltd 14.22 %	3,449,701	14.22 %	17 M ¥
Golden Trust Sinopac Fund Management Co., Ltd. 13.89 %	3,369,147	13.89 %	16 M ¥
Caitong Fund Management Co., Ltd. 2.921 %	708,511	2.921 %	3 M ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 1.377 %	334,060	1.377 %	2 M ¥
Truvalue Asset Management Co. Ltd. 0.8430 %	204,480	0.8430 %	986 046 ¥
Huashang Fund Management Co., Ltd. 0.7375 %	178,881	0.7375 %	862 602 ¥
China Asset Management Co., Ltd. 0.6328 %	153,476	0.6328 %	740 094 ¥
Zhejiang Zheshang Securities Asset Management Co., Ltd. 0.1694 %	41,100	0.1694 %	198 193 ¥
Wanjia Asset Management Co., Ltd. 0.1398 %	33,915	0.1398 %	163 545 ¥
Fullgoal Fund Management Co., Ltd. 0.1373 %	33,300	0.1373 %	160 580 ¥

PharmaResources (Shanghai) Co., Ltd

Building 23 No. 315, Qingda Road

201201, Shanghai

http://www.pharmaresources.cn

address PharmaResources (Shanghai) Co., Ltd.(301230)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

32.49

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
PHARMARESOURCES (SHANGHAI) CO., LTD.	-9.25%	48Cr
MODERNA, INC.	+54.05%	5.87TCr
IQVIA HOLDINGS INC.	-2.02%	4.13TCr
LONZA GROUP AG	+38.48%	3.92TCr
CELLTRION, INC.	-10.22%	2.74TCr
ICON PUBLIC LIMITED COMPANY	+13.42%	2.65TCr
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	1.9TCr
BIO-TECHNE CORPORATION	+2.89%	1.25TCr
UNITED THERAPEUTICS CORPORATION	+22.40%	1.19TCr
MEDPACE HOLDINGS, INC.	+27.49%	1.21TCr

Other Biotechnology & Medical Research